EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Implications of inflammation and sex in lower extremity arterial disease

Katja Schnidrig, Manovriti Thakur iD, Aleksandra Tuleja, Sarah Maike Bernhard, Heidi Noels, Drosos Kotelis, Marc Schindewolf, Yvonne Döring iD

European Journal of Clinical Investigation · 2026

DOI: 10.1111/eci.70144 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Clinical Investigation, 2026. Verfasst von Katja Schnidrig und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Inflammation, Peripheral Arterial Disease, Lower Extremity. Die Arbeit nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerische Herzstiftung, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Novartis Stiftung für Medizinisch-Biologische Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lower extremity arterial disease (LEAD) affects over 200 million people globally and is largely driven by chronic vascular inflammation. However, the complex interplay between inflammatory pathways, their prognostic value and potential sex‐specific differences remains insufficiently understood. Methods and Results Literature indicates that elevated inflammatory markers—such as (high‐sensitivity) C‐reactive protein, fibrinogen, D‐dimer, interleukin‐6, α‐defensins and soluble adhesion molecules as well as newly arising parameters such as neutrophil counts and markers of clonal haematopoiesis—may predict both the onset and progression of LEAD, from declining ankle–brachial indices and impaired walking performance to higher rates of amputation, cardiovascular events and mortality. Moreover, women with LEAD frequently present at older ages with more advanced disease, exhibit distinct lesion patterns and greater functional impairment, and often have higher baseline CRP levels than men, although the strength of association between inflammatory markers and adverse outcomes may be attenuated in women. However, it remains unclear how inflammatory markers can guide (sex) specific patient stratification in LEAD or which markers provide the most clinical utility in general.

Conclusion

Together, these findings underscore the need for comprehensive inflammatory profiling in LEAD risk stratification and highlight the importance of joining sex‐specific analyses, new (bio)markers and machine learning to integrate clinical, genomic, proteomic and functional data into future studies to inform patient‐tailored prevention and treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammationPeripheral Arterial DiseaseLower ExtremityHumansFemaleC-Reactive ProteinSex FactorsMaleBiomarkersFibrin Fibrinogen Degradation ProductsFibrinogenInterleukin-6PrognosisAnkle Brachial Index

Stichwörter der Autor:innen

LEADatherosclerosisinflammationsex differences

Substanzen

C-Reactive ProteinBiomarkersFibrin Fibrinogen Degradation ProductsFibrinogenInterleukin-6

Autor:innen und Institutionen

  • Division of Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland.
  • Graduate School for Health Sciences, University of Bern, Bern, Switzerland.
  • Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany.
  • Department of Biochemistry, CARIM, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands.
  • Aachen-Maastricht Institute for Cardiorenal Disease (AMICARE), University Hospital RWTH Aachen, Aachen, Germany.

ORCID-Profile: Manovriti Thakur, Yvonne Döring

Förderung

  • Schweizerische Herzstiftung
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Novartis Stiftung für Medizinisch-Biologische Forschung
  • European Foundation for the Study of Diabetes (EFSD)
  • German Research Foundation (DFG)
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Schnidrig, K., Thakur, M., Tuleja, A., Bernhard, S. M., Noels, H., Kotelis, D., Schindewolf, M., & Döring, Y. (2026). Implications of inflammation and sex in lower extremity arterial disease. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.70144

Vancouver

Schnidrig K, Thakur M, Tuleja A, Bernhard SM, Noels H, Kotelis D, et al. Implications of inflammation and sex in lower extremity arterial disease. European Journal of Clinical Investigation. 2026. doi:10.1111/eci.70144

BibTeX
@article{Schnidrig2026,
  author = {Schnidrig, Katja and Thakur, Manovriti and Tuleja, Aleksandra and Bernhard, Sarah Maike and Noels, Heidi and Kotelis, Drosos and Schindewolf, Marc and Döring, Yvonne},
  title = {Implications of inflammation and sex in lower extremity arterial disease},
  journal = {European Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1111/eci.70144}
}
Kostenlos starten →